ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

CCOP Review Committees Listed

February 6, 1987

Fruits, Vegetables Protective Against Cancer, IARC Says

May 30, 2003

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Chemical Distribution To Grantees Delayed while HEW Considers Charging For It

June 22, 1979

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992